AI-generated image
Zen Technologies, once a beacon of India's burgeoning defence sector, has become a case study in how fast fortunes can turn in the market. A darling of investors for its anti-drone systems and combat training simulators, the company delivered a stunning rally—its stock surging over 12 times between March 2022 and December 2024. But the same market that once cheered its meteoric rise has now turned its back. In the last two months, the stock has shed over half its value.
What went right before it went wrong
The prior stock rally owes itself to staggering growth that mostly occurred in the last two years (FY23 and FY24), led by rapid government defence spending and the company's product pivot. Over the last five years, Zen's revenue and net profit have leapt 37 per cent and 57 per cent per annum, respectively.
Initially known for its combat training simulators, Zen pivoted aggressively into anti-drone technology post-2020, a move that paid off handsomely. Today, anti-drone systems account for over 50 per cent of its order book. This wasn't just a domestic play, either. The company's strategic push into exports saw foreign revenue share jump from zero before FY22 to 35 per cent of turnover in FY23.
Its order book ballooned from Rs 431 crore in FY22 to a peak of Rs 1,402 crore in FY24. A key accelerant was the government's 'indigenously designed, developed, and manufactured' (IDDM) policy. Designed to promote self-reliance in defence manufacturing, the IDDM classification gives priority to homegrown products in government contracts. Zen's anti-drone tech and simulators qualified under the policy, giving it a front-row seat in public tenders.
Why the tide turned
But markets are forward-looking creatures, and Zen's growth narrative has hit turbulence. The stock's steep fall in recent months isn't without reason.
- Order book concerns: The most immediate red flag is the shrinking order book—from Rs 1,402 crore at the end of FY24 to Rs 816 crore as of December 2024. Even more troubling is the lack of fresh orders in the past two quarters. In Q1 FY25, new order wins stood at a paltry Rs 11 crore. Such gaps raise legitimate concerns about future growth visibility.
- Valuation compression: Zen's astronomical run had pushed its P/E ratio north of 100 times by late 2024—a figure justifiable only with sustained hyper-growth. But with order inflows drying up, the narrative collapsed. Even after the stock's 50 per cent plunge, it still trades at 47x earnings, hardly a bargain, given the current uncertainty.
Just a bad quarter? Not quite
For long-term investors, the issue isn't just the recent slump. It's the underlying business model that merits scrutiny.
- Government dependency: defence is a high-stakes, high-reward sector, but it comes with strings attached. Zen's revenue pipeline is tethered to government contracts, both domestic and international. This makes its order flow inherently lumpy and vulnerable to policy shifts, budgetary constraints, or bureaucratic delays.
- Cyclical sales and volatile efficiency: The nature of tender-based contracts means Zen's revenues can swing wildly year to year. Over the past five years, its return on equity (ROE) fluctuated between one and 34 per cent, reflecting the inconsistent nature of its sales cycles.
- Poor cash flow conversion: Perhaps the most glaring red flag is Zen's poor EBITDA-to-CFO conversion. Over the past decade, it has converted just 40 per cent of its cumulative EBITDA into actual operating cash flow. The culprit? High working capital intensity. Receivable days routinely stretch nearly four months, while payables are settled in about two months, leaving the company constantly playing catch-up on cash.
A watch-and-wait game
Zen's management remains upbeat, targeting 50 per cent annual sales growth over the next three years, albeit with caution for FY26. The optimism hinges on an anticipated uptick in order inflows starting next quarter. But for now, that's just talk. Investors will want to see signed contracts, not forward guidance.
Zen Technologies is a classic tale of how markets price in sky-high expectations and how quickly they recalibrate when those expectations falter. The 50 per cent decline has sobered valuations, making it a bet to watch but not one to rush into, at least, not yet.
Also read: Railway PSU stocks are in freefall. Time to buy or wait?
Before you leave: Don't miss out on these 10 Peter Lynch stocks
Peter Lynch didn't chase market fads. He didn't bet on hype. He found great businesses, held onto them, and let compounding do the work.
If he were investing in India today, he'd pick companies with dominant market share, steady growth, and brands that people can't live without.
We've identified 10 such stocks—the kind Lynch would love. And they're all part of Value Research Stock Advisor's Long-term Growth Portfolio.
These are high-growth, fundamentally strong businesses designed to be long-term winners, not short-term bets.
The kind of stocks you buy and hold for years—just like Lynch did.
Don't miss out—see the full list and invest like a legend today.
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
